Jacobio Pharmaceuticals
Presença
Jacobio Pharmaceuticals é uma empresa listada sob o símbolo 1167 (HK).
Executivos
Veja o organograma con seus 18 executivos principais
Biografias mais buscadas da Jacobio Pharmaceuticals
- Yinxiang Wang, Chief Executive Officer and Chairman of the Board
- Song Ruilin, Non-Executive Director
- Bai Lu, Independent Non-executive Director
Criar um alerta
para seguir os movimentos de executivos da Jacobio Pharmaceuticals.
Farmacêutica
Jacobio Pharmaceuticals possui 1.867 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
- Frontier Medicines acaba de anunciar uma arrecadação de fundos de 80 milhões de dólares. (publicado em 27 de fevereiro de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Jacobio Pharmaceuticals
- Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting | Jacobio Pharma
- Jacobio Pharma Announces 2023 Annual Results | Jacobio Pharma
- Jacobio Pharma Receives IND Approval for P53 Y220C Activator JAB-30355 in the U.S. | Jacobio Pharma
- Jacobio Pharma Receives IND Approval for P53 Y220C Activator JAB-30300 in the U.S. | Jacobio Pharma
- Jacobio Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor | Jacobio Pharma
- Jacobio Pharma Presents Data of Glecirasib in Patients with Pancreatic Cancer and Other Solid Tumors at the 2024 ASCO GI | Jacobio Pharma
- Jacobio Pharma to Present Data of KRAS G12C Inhibitor Glecirasib in Patients with Pancreatic Cancer and Other Solid Tumors at the 2024 ASCO GI | Jacobio Pharma
- Jacobio Pharma Presents Clinical Results of Glecirasib in Combination with JAB-3312 at ESMO | Jacobio Pharma
- Jacobio Completes First Patient Dosage of Glecirasib in a Pivotal Clinical Trial for the Treatment of Pancreatic Cancer in China | Jacobio Pharma
- Jacobio Pharma Announces 2023 Interim Results | Jacobio Pharma
- View more press releases Close
Redes sociais sobre Jacobio Pharmaceuticals
- Jacobio Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Jacobio Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Yinxiang Wang 
Ligue para a Jacobio Pharmaceuticals em +86 105...
